PSS31 - COST PER RESPONDER OF SECUKINUMAB COMPARED TO OTHER BIOLOGICS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.2531
https://www.valueinhealthjournal.com/article/S1098-3015(18)35833-9/fulltext
Title :
PSS31 - COST PER RESPONDER OF SECUKINUMAB COMPARED TO OTHER BIOLOGICS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS FROM THE PRIVATE PAYER PERSPECTIVE IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35833-9&doi=10.1016/j.jval.2018.09.2531
First page :
Section Title :
Open access? :
No
Section Order :
1883